tm
Seeing Is Believing
tm
Seeing Is Believing
MLTX is currently covered by 12 analysts with an average price target of $25.67. This is a potential upside of $12.31 (39.66%) from yesterday's end of day stock price of $18.38.
MoonLake Immunotherapeutics's activity chart (see below) currently has 96 price targets and 120 ratings on display. The stock rating distribution of MLTX is 80.56% BUY, 16.67% HOLD and 2.78% SELL.
Analysts average stock forecasts to be materialized ratio is 22.2% with an average time for these price targets to be met of 80.58 days.
Highest price target for MLTX is $70, Lowest price target is $5, average price target is $25.67.
Most recent stock forecast was given by RAGHURAM SELVARAJU from HC WAINWRIGHT on 20-Jul-2026. First documented stock forecast 21-Jul-2022.
Currently out of the existing stock ratings of MLTX, 29 are a BUY (80.56%), 6 are a HOLD (16.67%), 1 are a SELL (2.78%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 20-Nov-2025
$45
$25.98 (136.59%)
$45
10 days ago
(20-Jul-2026)
8/36 (22.22%)
$25.95 (136.22%)
86
Buy Since 09-Feb-2026
$30
$10.1 (50.75%)
$30
1 months 21 days ago
(09-Jun-2026)
2/10 (20%)
$12.2 (68.54%)
61
Buy Since 31-Aug-2023
$30
$10.1 (50.75%)
$25
2 months 18 days ago
(12-May-2026)
1/16 (6.25%)
$11.81 (64.93%)
265
Sell Since 23-Mar-2026
$24
$4.1 (20.60%)
$61
4 months 7 days ago
(23-Mar-2026)
1/2 (50%)
$7.13 (42.26%)
112
Buy Since 12-Dec-2024
$70
$50.1 (251.76%)
4 months 19 days ago
(11-Mar-2026)
0/2 (0%)
$52.16 (292.38%)
What is MLTX (MoonLake Immunotherapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on MLTX (MoonLake Immunotherapeutics) with a proven track record?
Which analyst has the most public recommendations on MLTX (MoonLake Immunotherapeutics)?
Which analyst is the currently most bullish on MLTX (MoonLake Immunotherapeutics)?
Which analyst is the currently most reserved on MLTX (MoonLake Immunotherapeutics)?
